anmelden
OMX Nordic 40
2.616,70
PKT
+0,46
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 30.01.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | S&P Capital IQ | |
| 26.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal weight | Barclays Capital | |
| 26.01.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 26.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novo Nordisk Hold | Commerzbank AG | |
| 24.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.01.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 23.01.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 23.01.17 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 23.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.01.17 | Volvo (B) Underweight | Morgan Stanley | |
| 19.01.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 19.01.17 | Novo Nordisk buy | UBS AG | |
| 19.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 19.01.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 19.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 18.01.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 18.01.17 | AstraZeneca overweight | Morgan Stanley | |
| 18.01.17 | Volvo (B) Underweight | Morgan Stanley | |
| 18.01.17 | Volvo (B) buy | Jefferies & Company Inc. | |
| 18.01.17 | AstraZeneca buy | Deutsche Bank AG | |
| 17.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 17.01.17 | Nokia buy | UBS AG | |
| 12.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.01.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 11.01.17 | Volvo (B) Underweight | Barclays Capital | |
| 11.01.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |